Cholangiocarcinoma Foundation 7th Annual Conference

胆管癌基金会第七届年会

• 批准号: 9911546
• 负责人: Stacie Lindsey
• 金额: $ 0.5万
• 依托单位: CHOLANGIOCARCINOMA FOUNDATION
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-03-01 至 2021-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9911546
• 关键词: Address; Advocate; Affect; Anatomy; Attention; Basic Science; Bile duct carcinoma; Caregivers; Cholangiocarcinoma; Cities; Clinical; Clinical Research; Clinical Treatment; Collaborations; Communities; Consensus; Development; Diagnosis; Disease; Early Diagnosis; Education; Epidemiology; Event; Fostering; Foundations; Future; Gastroenterology; Genetic; Goals; Health; Immunotherapy; Incidence; Industry; International; Knowledge; Lead; Liver; Malignant Neoplasms; Medical; Mentorship; Mission; Oncology; Oral; Outcome; Participant; Pathologic; Patient-Focused Outcomes; Patients; Prevalence; Prevention; Prevention strategy; Public Health; Quality of life; Research; Research Personnel; Resources; Risk Factors; Science; Scientific Advances and Accomplishments; Sodium Chloride; Symptoms; Training; Translational Research; United States National Institutes of Health; Utah; Work; aggressive therapy; bench to bedside; bile duct; cancer diagnosis; career; clinically relevant; design; evidence base; experience; high risk population; improved; innovation; meetings; mortality; multidisciplinary; novel therapeutics; outcome forecast; patient engagement; posters; prevent; symposium

Project Summary As a rare and lethal disease, cholangiocarcinoma (CCA) lacks attention and resources. There is a vast unmet need for education across the entire disease spectrum from bench-to-bedside. As such, the Cholangiocarcinoma Foundation continues to focus its efforts to educate all stakeholders in the cholangiocarcinoma community-at-large. Paramount to that effort, the 2020 Annual Conference has been developed with the following objectives: 1) Increasing the knowledge and understanding of attendees about key issues central to the prevention, diagnosis, treatment, and cure for cholangiocarcinoma; 2) Identifying gaps and gathering consensus on rapidly changing advances in basic, translational, and clinical research; 3) Stimulating international, multi-disciplinary, cross-cooperation and sharing of best practices by developing, strengthening, and supporting collaborations; 4) Fostering dialogue and inspiring innovation. A multidisciplinary audience, including representatives of the scientific, medical and academic communities; policymakers and regulators, industry, advocates, patients and caregivers will convene to present a diversity of perspectives focused on evidence-based opinion, compare current developments, and summarize emerging developments in basic, translational and clinical research defining the field of CCA. A global community of experts will review symptoms, incidence, and prevalence in high risk populations (prevention); examine epidemiological and pathological features of the heterogeneous group of 3 anatomically distinct cancers (diagnosis); and review advances in oncology research that are likely to be clinically relevant (treatment and cure). This setting will also provide a forum to attract and nurture early career researchers with opportunities to develop and expand their education with mentorship from a global community of renowned experts. Through oral abstracts, poster sessions, speaker presentations, patient engagement and more, Young Investigators will forge new alliances, stimulate dialogue and accelerate global CCA research with the common goal of supporting the Foundation's mission to find a cure and improve the quality of life for those affected by CCA.

项目总结